Neuberger Berman Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2K Sell
12,842
-1,613
-11% -$5.11K ﹤0.01% 2127
2025
Q4
$53.5K Buy
+14,455
New +$46.7K ﹤0.01% 2052
2025
Q3
Sell
-14,250
Closed -$14K 2070
2025
Q2
$14K Buy
14,250
+1,894
+15% +$1.9K ﹤0.01% 2036
2025
Q1
$17.8K Buy
12,356
+1,635
+15% +$3.01K ﹤0.01% 1944
2024
Q4
$23.6K Hold
10,721
﹤0.01% 1907
2024
Q3
$17.7K Buy
+10,721
New +$21.6K ﹤0.01% 1905
2023
Q3
Sell
-15,899
Closed -$22.1K 1830
2023
Q2
$22.1K Buy
+15,899
New +$22.2K ﹤0.01% 1773
2018
Q2
Sell
-18,000
Closed -$1.3M 1720
2018
Q1
$1.3M Buy
+18,000
New +$1.32M ﹤0.01% 1109
2017
Q3
Sell
-16,500
Closed -$764K 1613
2017
Q2
$764K Buy
+16,500
New +$607K ﹤0.01% 1219
2015
Q3
Sell
-20,341
Closed -$1.66M 1545
2015
Q2
$1.66M Buy
20,341
+12,466
+158% +$1.22M ﹤0.01% 1103
2015
Q1
$729K Buy
+7,875
New +$508K ﹤0.01% 1269
2013
Q4
Sell
-22,550
Closed -$425K 1626
2013
Q3
$425K Buy
+22,550
New +$379K ﹤0.01% 1348

Other funds holding ESPR